Call Toll Free:
1 (855) MEDVIN-1
Gout Trials
The study utilizes an already FDA approved drug for the treatment of Gout that helps lower the Uric Acid levels in patients. The patients DO NOT need to be on a Gout medication. Gout is a type of inflammatory arthritis caused by the accumulation of urate crystals in the joints, resulting in severe pain, swelling, and inflammation. This study aims to assess the potential of new therapies in managing gout symptoms and improving patient outcomes. The sponsor will provide Methotrexate medication to participants during the study.
Trial Details
Participation Criteria
Must have a diagnosis of PsA for at least 6 months.
BMI over 27 (Obesity or Overweight)
Must have 3 tender, 3 swollen joints
Exclusion: Not qualified with a HX of Type 1 or 2 Diabetes
Exclusion: Have a prior or planned surgical treatment for obesity
Participating Locations
-
Covina
-
Whittier
-
Riverside
-
Tujunga
-
Temecula
-
Menifee
-
Earn up to $ 4,800 total
-
$100 per visit for a total of 48 visits
Compensation
-
FDA approved drug (No Placebo involved) all subject will receive active medication.
Medications
-
16-month study (Double-blind period 23 weeks, followed by Open-label extension week 24 - week 44).